Shire Opts To Buy NPS Pharmaceuticals For $5.2 Billion

Shires pays $5.2 billion in an all cash transaction to acquire NPSP.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.